td-8954
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2012 (NCT01644240)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Serotonin 4 (5-HT4) receptorAGONIST
HTR4 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- 4-((4-((2-isopropyl-1h-benzoimidazole-4-carbonyl)amino)methyl)piperidin-1-ylmethyl)piperidine-1-carboxylic acid methyl ester
- td-8954
- td-8954
- td-8954
- td-8954
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01953081 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2014 | Theravance |
| NCT01644240 | Phase 1 | Sep 1, 2012 | Theravance |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Theravance | For profit | 2 | 2 | 2 | 2012 |
1 organizations
Page 1 / 1